Literature DB >> 2710690

Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors.

K Oishi1, K Okada, O Yoshida, H Yamabe, Y Ohno, R B Hayes, F H Schroeder.   

Abstract

Demographic risk factors for prostatic cancer were examined in a case-control study of 100 triplets of prostatic cancer patients and age-, hospital-, and admission date-matched control series of benign prostatic hyperplasia (BPH) patients and general hospital patients. A higher risk of prostatic cancer was associated with the following factors: 1) long-term occupation in transport or communication (relative risk [RR] = 4.92, 95% confidence interval [CI]: 1.18-20.5) as compared with hospital controls; 2) the wife having a lower educational level (RR = 1.88, 95%CI: 1.02-3.45) as compared with hospital controls; 3) no past episode of hypertension as compared with BPH controls (RR = 2.30, 95%CI: 1.27-4.15); 4) having several sisters (more than four) as compared with both BPH and hospital controls (RR = 3.82, 95%CI: 1.35-10.8 and RR = 2.94, 95%CI: 1.08-8.03 respectively); 5) dense body hair as compared with hospital controls (RR = 4.28, 95%CI: 1.19-15.4). No significant links were found with blood type, daily drug use, head hair, skin color, body type, smoking habits, religion, body weight, and mental characteristics.

Entities:  

Mesh:

Year:  1989        PMID: 2710690     DOI: 10.1002/pros.2990140205

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

1.  Gonorrhea infection increases the risk of prostate cancer in Asian population: a nationwide population-based cohort study.

Authors:  Y-C Wang; C-H Chung; J-H Chen; M-H Chiang; C-H Tsao; F-H Lin; W-C Chien; S-T Shang; F-Y Chang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-24       Impact factor: 3.267

Review 2.  Multiple pathogens and prostate cancer.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Infect Agent Cancer       Date:  2022-05-30       Impact factor: 3.698

3.  Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.

Authors:  Cindy Ke Zhou; Alyson J Littman; Paul H Levine; Heather J Hoffman; Sean D Cleary; Emily White; Michael B Cook
Journal:  Prostate       Date:  2014-12-09       Impact factor: 4.104

4.  Associations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese men.

Authors:  Xi Lu; Yuko Yamano; Hiroyuki Takahashi; Masahide Koda; Yuki Fujiwara; Aya Hisada; Wataru Miyazaki; Takahiko Katoh
Journal:  Environ Health Prev Med       Date:  2015-08-07       Impact factor: 3.674

5.  Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Cindy Ke Zhou; Ruth M Pfeiffer; Sean D Cleary; Heather J Hoffman; Paul H Levine; Lisa W Chu; Ann W Hsing; Michael B Cook
Journal:  J Clin Oncol       Date:  2014-09-15       Impact factor: 44.544

6.  Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases.

Authors:  Mohamad Salih Jaff
Journal:  Int J Nanomedicine       Date:  2010-11-02

7.  Reliability of hamilton-norwood classification.

Authors:  M Guarrera; P Cardo; P Arrigo; A Rebora
Journal:  Int J Trichology       Date:  2009-07

8.  Socio-economic and lifestyle factors associated with the risk of prostate cancer.

Authors:  T I Lund Nilsen; R Johnsen; L J Vatten
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

9.  Gonorrhea and Prostate Cancer Incidence: An Updated Meta-Analysis of 21 Epidemiologic Studies.

Authors:  Wen-Qing Lian; Fei Luo; Xian-Lu Song; Yong-Jie Lu; Shan-Chao Zhao
Journal:  Med Sci Monit       Date:  2015-07-01

10.  An epidemiological analysis of potential associations between C-reactive protein, inflammation, and prostate cancer in the male US population using the 2009-2010 National Health and Nutrition Examination Survey (NHANES) data.

Authors:  Catherine A St Hill; M Nawal Lutfiyya
Journal:  Front Chem       Date:  2015-08-28       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.